MannKind Corp. (MNKD)

[DownWithPumpers]

Compare the two companies.

Mannkind had:
1. an astronomical 3 billion dollar market cap
2. no cash to bring its product to market
3. no niche except people who have a psychological fear of needles
4. a huge short interest

FLXN:
1. sells for 800 million more than its cash level
2. services an unmet need for people who are in for a lifetime of chronic pain
3. a nominal short interest

I was here after the Sanofi deal pointing out that its terms were the most obvious sell signal in the world. Up until the last week before Sanofi dumped Mannkind everyone was saying what a great job Sanofi was doing.

In any case, going forward without Sanofi is going to mean massive dilution. The bad news for Mannkind is right around the corner. It's going to be no more easy days.